Skip to content

Dietary Cholesterol and Defects in Cholesterol Synthesis in Mevalonate Kinase Deficiency

Dietary Cholesterol and Defects in Cholesterol Synthesis in Mevalonate Kinase Deficiency

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00260299
Enrollment
1
Registered
2005-12-01
Start date
2005-02-28
Completion date
2016-01-31
Last updated
2019-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immune System Diseases, Lipid Metabolism, Inborn Errors, Mevalonate Kinase Deficiency, Mevalonic Aciduria, Periodic Fever Syndromes, Hereditary

Keywords

cholesterol defects, Mevalonic Aciduria, Mevalonate Kinase Deficiency, HIDS, Hyperimmunoglobulinemia with periodic fever syndrome, MKD, Lipid Metabolism, Inborn Errors, Periodic Fever Syndromes, hereditary, mevalonic acid, mevalonate kinase, cholesterol, dietary, Hyper IgD, Multiple malformations, Fever

Brief summary

Participants wanted for study of mevalonate kinase deficiency (MKD), mevalonic aciduria, or hyperimmunoglobulinemia with periodic fever syndrome (HIDS). Patients with MKD (mevalonic aciduria or hyperimmunoglobulinemia with periodic fever syndrome (HIDS)) may be eligible for a research study conducted at Oregon Health & Science University (OHSU) in Portland, Oregon USA. The purpose of the study is to find out more about how these diseases affect body chemistry and health. The researchers also want to find out how cholesterol in the diet affect blood cholesterol and how the body handles cholesterol. This is a short-term and long-term dietary study. The long-term goal of this research is to see if controlling dietary cholesterol can decrease any of the symptoms of the diseases. The study could involve up to 12 one-week admissions to OHSU over the course of 5 years.

Detailed description

Participants are admitted to the clinical research center for up to a week per visit. Additional visits at least yearly encouraged. During the week we measure such things as cholesterol absorption, sterol and bile acid synthesis, mevalonate and mevalonate shunt products, isoprenoids, fatty acids, leukotrienes, plasma cholesterol and other sterol levels. Also, the effects of altering dietary cholesterol on plasma 24-S OH-cholesterol, a measure of brain cholesterol turnover, will be evaluated. Studies of body composition/ metabolism/ growth, development, behavior, sleep, feeding, hearing and vision will be carried out to document the phenotype and determine if dietary intervention may be helpful. The objective of the study is to characterize the metabolic and phenotypic consequences of MKD and study the effects of altering dietary cholesterol in MKD. We hypothesize that some of the phenotypic effects of MKD are due to altered cholesterol metabolism, but that the phenotype is predominantly due to derangements in isoprenoid metabolism.

Interventions

None listed

Sponsors

Oregon Health and Science University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Must have documented mevalonate kinase deficiency, mevalonic aciduria, or HIDS * Must be willing to participate in most research procedures

Exclusion criteria

* Unable or unwilling to participate in most research procedures

Design outcomes

Primary

MeasureTime frameDescription
Determine the effects of dietary cholesterol changes in MKD on cholesterol and related synthetic pathwaysDecember 2011blood levels of cholesterol

Secondary

MeasureTime frameDescription
Define genotype, phenotype and response to dietary cholesterol. Determine genotype-therapy correlations.December 2011Gene Mutations - 7-dehydrocholesterol levels

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026